Effectiveness of Continuous Glucose Monitoring in Patients With Type 2 Diabetes Treated With Basal Insulin

JAMA

EMBARGOED FOR RELEASE: 3:15 P.M. (ET), WEDNESDAY, JUNE 2, 2021

Media advisory: The full study and editorial are linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.7444?guestAccessKey=9dfa22ea-0705-456a-8773-7279c904bbeb&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060221

 

Visual Abstract

 

Authors: Roy W. Beck, M.D., Ph.D., of the Jaeb Center for Health Research in Tampa, Florida, is the corresponding author.

(doi:10.1001/jama.2021.7444)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.